Skip to content
About
Pipeline
MB-105
News & Publications
About
Pipeline
MB-105
News & Publications
Contact
Contact
About
Pipeline
MB-105
News & Publications
About
Pipeline
MB-105
News & Publications
March Biosciences Announces Appointment of Gurpreet Ratra, Ph.D., as Chief Business Officer
December 3, 2025
8:00 am
Prev
Previous
March Biosciences Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for MB-105 in Relapsed/Refractory CD5-Positive T-Cell Lymphoma
Next
March Biosciences Presents Positive Interim Clinical Data from Phase 2 Trial of MB-105 CD5 CAR-T Cell Therapy at ASH 2025 Annual Meeting
Next
Scroll Up
